Pfizer ANNOUNCES JV and 3 Dow Movers Trading Today
Johnson & Johnson’s (NYSE:JNJ) Bengay is among a few over-the-counter pain relievers that are subject to an FDA warning, which says that some consumers have reported receiving serious skin injuries during their use. It appears that then when applied to the skin to relieve mild muscle and joint pain, there have been some 43 reported cases of burns linked to the active ingredients menthol, methyl salicylate and capsaicin. A Thursday FDA press release indicated that the the injuries have ranged from mild to severe chemical burns; Sanofi-aventis’ (NYSE:SNY) Icy Hot is another product in the group.
JPMorgan Chase & Co. (NYSE:JPM): It is reported that underwriters are permitting corporate insiders to work around the usual agreements that would disallow them from quickly divesting shares following initial public offerings, according to the Wall Street Journal. As is typical with these lockups, underwriters keep company insiders from selling their shares, usually for 180 days subsequent to an IPO, but this year the insiders have seen 10 such agreements expire early, at times even months prior to the planned exit date.
Microsoft Corporation (NASDAQ:MSFT): Tablet PCs are forecast to reduce e-book reader and notebook sales in the second half of 2012, says DigiTimes, citing market observers, adding that tablet products such as the Kindle Fire HD, Nexus 7, and the reported 7.85-inch iPad are enjoying higher demand.
Pfizer Inc. (NYSE:PFE) and Zhejiang Hisun Pharmaceuticals have introduced the startup of their Hisun-Pfizer Pharmaceuticals Co., Ltd. joint venture to develop, produce and commercialize off-patent pharmaceutical products in China and in worldwide markets. This move represents an important step in strengthening the ability of both firms to allow more patients access to high-quality and low-cost branded generic medicines.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>